Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Akoya BioSciences (AKYA)

Akoya BioSciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AKYA
DateTimeSourceHeadlineSymbolCompany
13/05/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AKYAAkoya BioSciences Inc
13/05/202421:00GlobeNewswire Inc.Akoya Biosciences Reports First Quarter 2024 Financial ResultsNASDAQ:AKYAAkoya BioSciences Inc
09/05/202413:00GlobeNewswire Inc.Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma PatientsNASDAQ:AKYAAkoya BioSciences Inc
06/05/202413:00GlobeNewswire Inc.Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, MassachusettsNASDAQ:AKYAAkoya BioSciences Inc
02/05/202413:00GlobeNewswire Inc.Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical WorkflowsNASDAQ:AKYAAkoya BioSciences Inc
22/04/202421:05GlobeNewswire Inc.Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024NASDAQ:AKYAAkoya BioSciences Inc
05/04/202413:00GlobeNewswire Inc.Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and ScaleNASDAQ:AKYAAkoya BioSciences Inc
04/03/202422:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AKYAAkoya BioSciences Inc
04/03/202421:05GlobeNewswire Inc.Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial OutlookNASDAQ:AKYAAkoya BioSciences Inc
04/03/202411:01Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:AKYAAkoya BioSciences Inc
02/03/202402:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKYAAkoya BioSciences Inc
02/03/202402:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKYAAkoya BioSciences Inc
02/03/202402:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKYAAkoya BioSciences Inc
02/03/202402:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKYAAkoya BioSciences Inc
02/03/202402:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKYAAkoya BioSciences Inc
02/03/202402:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKYAAkoya BioSciences Inc
02/03/202402:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKYAAkoya BioSciences Inc
12/02/202414:11Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AKYAAkoya BioSciences Inc
08/02/202421:05GlobeNewswire Inc.Akoya to Report Fourth Quarter and Full Year 2023 Financial Results on March 4th, 2024 and Participate at an Upcoming Investor ConferenceNASDAQ:AKYAAkoya BioSciences Inc
18/01/202413:00GlobeNewswire Inc.Akoya Biosciences’ Technology Enables Queensland Spatial Biology Centre to Revolutionize the Diagnosis and Treatment of Cancer and Other DiseasesNASDAQ:AKYAAkoya BioSciences Inc
10/01/202421:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AKYAAkoya BioSciences Inc
10/01/202413:00GlobeNewswire Inc.Akoya Biosciences Announces that Garry Nolan, Ph.D., James Allison, Ph.D., and Padmanee Sharma, M.D., Ph.D., Join Newly Created Scientific Advisory BoardNASDAQ:AKYAAkoya BioSciences Inc
08/01/202420:57Dow Jones NewsAkoya Biosciences Shares Jump on 2024 Outlook, Thermo Fisher DealNASDAQ:AKYAAkoya BioSciences Inc
08/01/202411:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AKYAAkoya BioSciences Inc
07/01/202413:00GlobeNewswire Inc.Akoya Biosciences Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2023 and Provides 2024 OutlookNASDAQ:AKYAAkoya BioSciences Inc
07/01/202413:00GlobeNewswire Inc.Akoya Biosciences and Thermo Fisher Scientific Announce a License and Distribution Agreement to Deliver Spatial Multiomics WorkflowNASDAQ:AKYAAkoya BioSciences Inc
07/01/202413:00GlobeNewswire Inc.Akoya Biosciences Deploys the MaxFuse Algorithm Co-Developed by Dr. Garry Nolan and His Laboratory at Stanford University for Multiomic Integration of Spatial and Single-cell Data on the Enable Medicine PlatformNASDAQ:AKYAAkoya BioSciences Inc
03/01/202413:50Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AKYAAkoya BioSciences Inc
21/12/202300:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKYAAkoya BioSciences Inc
20/12/202313:05GlobeNewswire Inc.Akoya to Participate at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:AKYAAkoya BioSciences Inc
 Showing the most relevant articles for your search:NASDAQ:AKYA